| 摘要 |
<p>The invention relates to compounds of the general formula (I) wherein HET and R?1 to R12¿ have the significances as defined in the specification, as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of formula (I) are group I mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.</p> |
